MIAMI--(BUSINESS WIRE)--Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS, LTS PrA), announced today that Christopher S. James, M.D. has been appointed as Managing Director, Equity Research at Ladenburg Thalmann & Co. Inc. covering biotechnology. Dr. James is based in Ladenburg’s New York office.
David Rosenberg, Co-President and Chief Executive Officer of Ladenburg Thalmann & Co. Inc., said, “We are delighted to welcome Chris to Ladenburg. Chris has differentiated himself in the market with his experience covering a wide range of biotechnology companies and unique background as a physician, specifically as a neurosurgeon. We look forward to his insights and expertise as the newest member of our biotechnology team.”
Dr. James joins Ladenburg with more than a decade of experience as a biotechnology analyst focused on small, mid and large-cap companies across multiple therapeutic areas. Most recently, he served as Senior Biotechnology Equity Research Analyst at FBR Capital Markets. Prior to joining FBR, Dr. James held Senior Analyst roles at Brinson Patrick Securities, MLV & Co. and Rodman & Renshaw. Dr. James also previously served as the first Chief Medical Officer of Retrophin Inc., a public biotechnology company focused on developing orphan drug therapies to treat rare diseases, and managed business development at Daiichi Sankyo, Inc.
Dr. James received a Medical Degree from the Yale University School of Medicine and a Bachelor of Science in Biology from Cornell University. He is a licensed physician with training in general surgery, neurology and neurosurgery from Weill-Cornell New York Hospital and Memorial Sloan Kettering Cancer Center.
About Ladenburg
Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS, LTS PrA) is a publicly-traded diversified financial services company based in Miami, Florida. Ladenburg’s subsidiaries include industry-leading independent broker-dealer firms Securities America, Inc., Triad Advisors, Inc., Securities Service Network, Inc., Investacorp, Inc. and KMS Financial Services, Inc., as well as Premier Trust, Inc., Ladenburg Thalmann Asset Management Inc., Highland Capital Brokerage, Inc., a leading independent life insurance brokerage company, and Ladenburg Thalmann & Co. Inc., an investment bank which has been a member of the New York Stock Exchange for over 135 years. The company is committed to investing in the growth of its subsidiaries while respecting and maintaining their individual business identities, cultures, and leadership. For more information, please visit www.ladenburg.com.
